Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues

Conflicting results have been reported so far in pooled analyses and studies evaluating the optimum duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients. However, randomized clinical trials dedicated to this specific setting of higher thrombotic risk patients have o...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdoia, Monica, Camaro, Cyril, Kedhi, Elvin, Marcolongo, Marco, Suryapranata, Harry, De Luca, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166288/
https://www.ncbi.nlm.nih.gov/pubmed/32328172
http://dx.doi.org/10.1155/2020/6495036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166288/
https://www.ncbi.nlm.nih.gov/pubmed/32328172
http://dx.doi.org/10.1155/2020/6495036

Ejemplares similares